Interactive Pharma Product Launched

US agencies Decision Resources and PharMetrics are to work together on a new interactive product, DecisionMETRICS(tm), to enhance the way pharmaceutical companies analyze their disease markets.

The launch promises companies the chance to accurately assess potential market size and identify untapped patient populations, identify key pointers for product positioning, highlight potential target patient groups and assess the impact of emerging therapies.

DecisionMETRICS will cover a wide selection of therapeutic areas including metabolic diseases, central nervous system disorders, immune and inflammatory diseases, and many more.

According to Sarah Fuller, President of Decision Resources, the partnership will combine Decision Resource's analysis and interviews with thought leading physicians with PharMetrics' unique patient-centric database. The latter uses 'encrypted' (ie anonymous) data from a network of over 80 health plans around the country, strictly adhering to the requirements of the Health Insurance Portability and Accountability Act (HIPAA).

Michael Weintraub, President and CEO of PharMetrics adds: 'The beauty of DecisionMETRICS is that it combines epidemiological, patient-level, and primary market research data into one comprehensive package. Whereas pharmaceutical marketers normally spend a lot of time reconciling these data sources themselves, DecisionMETRICS has already done the work for them'.

The partners are on the web at www.pharmetrics.com and www.decisionresources.com

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Clarivate Plc
• All news